Goldman Sachs Has 4 Red-Hot Biotech Stocks to Buy Under $10
These four sizzling biotech stocks trading under the $10 level have big upside to the analysts' price targets. All of them are rated Buy at Goldman Sachs.
These four sizzling biotech stocks trading under the $10 level have big upside to the analysts' price targets. All of them are rated Buy at Goldman Sachs.
Friday's top analyst upgrades and downgrades included Advanced Micro Devices, Cloudflare, Dell Technologies, Lending Tree, Netflix, Tractor Supply, Twilio and Under Armour.
Analysts at Goldman Sachs make the case that the quarter could be very strong for some of the top stocks in the aerospace and defense sector. These three are top picks ahead of second-quarter…
Thursday's top analyst upgrades and downgrades included Cisco Systems, Dell Technologies, Dollar Tree, Hubspot, Jabil, Kraft Heinz, Novavax, Peloton Interactive, Shopify and Walt Disney.
See why UBS feels these 10 stocks in a variety of sectors with solid upside potential could do very well with a Trump victory in November.
See why UBS feels these 10 stocks in a variety of sectors with solid upside potential could do very well with a Joe Biden victory in November.
Jefferies considers these five top financial stocks to be incredible values now, and with bank earnings for the big money center players coming this week, it may be time to jump in.
These five stocks from the Analyst Current Favorites list at Raymond James all have a degree of a contrarian play to them, and all offer outstanding value in a time when the stock market…
24/7 Wall St. presents five well-known companies that are likely to survive the current troubles and shares of which could very well offer patient investors some huge returns over the next year or so.
Friday's top analyst upgrades and downgrades included Beyond Meat, Charter Communications, Comerica, Equifax, Fastly, Harley-Davidson, Netflix, Splunk and Wells Fargo.
Any improvement in the overall economy and the COVID-19 situation could prove to be huge tailwinds for these five smaller stocks for the rest of this year and into 2021.
With the stock market way overbought, and many investors looking for value ideas, beaten-down energy giants may be an outstanding idea now. Investors that can see past the current environment could make some solid…
Jefferies is very bullish on these five semiconductor stocks. All are rated Buy and make great additions to aggressive growth portfolios.
With the market clearly close to or at full value again, it makes sense to look to areas where alpha can be generated for the rest of 2020. BofA Securities is out with its…
The coming earnings data will be horrific, and the domestic and geopolitical scene is messy, so rotating to dividend-paying stocks that offer better upside and total return potential might be a very good idea…
BofA Securities has made huge changes to its US 1 list of top stocks to buy. These five additions should fare well in the second half of 2020.
SunTrust Robinson Humphrey's lead software analyst sees a new software adoption cycle spurred on by the new era of innovative sales technologies. These four stocks could provide growth investors with big upside potential.
These are four top telehealth plays for growth investors that offer a way to not only catch the swelling trend but to have a health care position for portfolios that should remain strong for…
These four stocks offer investors strength in their specific industries, as well as the ability to generate some significant portfolio alpha. They are suitable for growth investors that have a larger degree of risk…
These five stocks trading under the $10 level have big upside to the Goldman Sachs price targets and could prove exciting additions to portfolios looking for solid alpha potential.